XBIO

1.4009.09%
GG

Grigory G. Borisenko

Independent Non-Executive Director

Dr. Grigory G. Borisenko, Ph.D., has been a Independent Non-Executive Director of Xenetic Biosciences, Inc. since September 25, 2019. He served as Director of Atea Pharmaceuticals, Inc. since March 2019 until October 29, 2020. He served as Investment Director of RUSNANO Management Company LLC since 2012 until March 31, 2022. He currently serves on the board of directors of Novamedica Limited Liability Company. Dr. Borisenko has scientific, management and strategic experience in Life science field. Dr. Borisenko has specialized in investment projects in Life science since 2012 and from 2009 through 2012, he was a head of the pharmaceutical sector of the Department of Science and Technology Expertise at the state corporation, RUSNANO. Dr. Borisenko currently serves on the Board of Director of Adastra Pharmaceuticals, Inc. and from 2011 to 2014, served on the board of directors of Nearmedic Pharm LLC and RusnanoMedInvest LLC. He served as Director of Atea Pharmaceuticals, Inc. from 2019 to 2020. Prior to his investment career, Dr. Borisenko held academic appointments with the University of Pittsburgh, Russian State Medical University and Institute of Medico-Biological Problems. He has co-authored over 50 peer-reviewed publications in leading biochemistry and cell biology journals. Dr. Borisenko received his M.S. and Ph.D. from the Russian State Medical University and is a recipient of Fogarty International and International Fellowship Awards from NIH.

Positions